4/A: Core Scientific CEO Amends RSU Tax Withholding Report

Core Scientific's CEO, Adam Taylor Sullivan, filed an amended Form 4 to correct the number of shares withheld for tax obligations related to restricted stock unit vesting.

Summary

• Adam Taylor Sullivan, Chief Executive Officer and Director of Core Scientific, Inc. (CORZ), filed an amended Form 4 on February 2, 2026.
• The amendment corrects an inadvertent error in the original Form 4 filed on January 26, 2026.
• On January 29, 2026, 274,554 shares of Common Stock were withheld to satisfy withholding tax obligations upon the vesting of restricted stock units.
• The shares were valued at $18.79 per share for this transaction.
• Following this transaction, Adam Taylor Sullivan beneficially owns 4,131,150 shares of Core Scientific Common Stock.
• The transaction was made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a neutral to slightly positive event. While an amendment was required, the underlying transaction is a routine, non-discretionary tax withholding, and the CEO retains a substantial equity stake.

Positives

• The transaction represents a routine tax withholding event upon RSU vesting, not a discretionary sale by the CEO.
• The CEO continues to hold a substantial number of shares (4,131,150), indicating ongoing alignment with shareholder interests.

Negatives

• A minor administrative error in the initial filing required an amendment, though the impact is negligible.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that routine insider transaction reports, especially those related to RSU vesting and tax withholding, are common across all industries and typically do not signal significant operational or strategic shifts. This filing is purely administrative.

Comparison to Industry Standards

• This type of transaction (shares withheld for tax upon RSU vesting) is a standard practice for executive compensation in publicly traded companies across various sectors, including technology and cryptocurrency mining.
• It aligns with typical compensation structures seen at companies like Marathon Digital Holdings (MARA) or Riot Platforms (RIOT), where executives receive equity as part of their remuneration, leading to similar tax-related share dispositions upon vesting.

Stakeholder Impact

• Shareholders: Minimal direct impact as it's a routine tax-related transaction, not a discretionary sale. The CEO's continued significant ownership aligns interests.
• Employees: No direct impact mentioned.
• Customers/Suppliers/Creditors: No direct impact mentioned.

Key Dates

Recommendation

This filing is an administrative correction of a routine insider transaction (tax withholding on RSU vesting) and does not provide new information that would fundamentally alter the investment thesis for Core Scientific. The CEO's substantial remaining equity stake is a positive, but the filing itself offers no catalysts for a 'buy' or 'sell' recommendation.

Keywords

Core Scientific, CORZ, Adam Taylor Sullivan, Form 4/A, Insider Transaction, Restricted Stock Units, RSU Vesting, Tax Withholding, CEO, Director, Beneficial Ownership